I listened with interest and suffered an initial feeling of dread when he spoke of introducing a new brain volume primary endpoint. It took me back to the meeting after their failed reach2 HD results came in. There was a measurable reduction on brain atrophy, but it was not an endpoint. I can recall some investors mocking a statement at that meeting, that if they had included brain volume as an endpoint, the trial would have been a success. Seems like they didn't need AI to measure brain volume back then. That drug was also a chelator. Some brain atrophy every year is normal, so even slowing atrophy to normal rate of decline may be enough.
- Forums
- ASX - By Stock
- Ann: Webcast Today - New Data from bioMUSE Natural History Study
I listened with interest and suffered an initial feeling of...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $34 | 10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 17196248 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 130790145 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 17196248 | 0.003 |
64 | 88003179 | 0.002 |
28 | 140710099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 129653155 | 26 |
0.005 | 18848455 | 22 |
0.006 | 22089363 | 18 |
0.007 | 54073650 | 25 |
0.008 | 42418463 | 31 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |